Farmacéuticos de Atención Primaria最新文献_第5页

Tratamiento antiplaquetario dual durante más de 12 meses tras la implantación de un stent recubierto: beneficios y riesgos por definir 涂层支架植入后超过12个月的双重抗血小板治疗:益处和风险有待确定

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70035-8

E. Marroquín, A. A. Ruiz, E. H. Álvarez

引用次数: 0

Persistencia en el tratamiento para la osteoporosis en pacientes posmenopáusicas en el ámbito de la Atención Primaria 初级保健领域绝经后患者骨质疏松症治疗的持续性

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70027-9

A. Sicras Mainar , R. Navarro Artieda , L. Gutiérrez Nicuesa , F. Sorio Vilela , M. Intorcia

引用次数: 1

El tratamiento intensivo con estatinas no reduce significativamente los episodios vasculares mayores y aumenta la incidencia de miopatía 他汀类药物强化治疗不能显著减少重度血管发作，增加肌病的发生率

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70043-7

B. García Robredo , V. Olmo Quintana , E. Candela Marroquín

引用次数: 0

Evaluación y selección de medicamentos 药物的评估和选择

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70041-3

J. Garjón Parra

引用次数: 1

Aplicación de los nuevos criterios de prescripción inadecuada STOPP-START a pacientes geriátricos institucionalizados 将新的停止-启动不充分处方标准应用于老年住院患者

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70012-7

J.M. Sotoca Momblona , H. Anglada Martínez , G. Molas Ferrer , S. Fontanals Martínez , M. Rovira Illamola , L. Sebastián Montal

引用次数: 15

Web 2.0 para farmacéuticos de Atención Primaria

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70013-9

C. Fernández Oropesa

引用次数: 1

Tiotropio asociado a cortoicoides inhalados mejora la función pulmonar en asma sin aportar suficiente evidencia en variables clínicas 噻托溴铵与吸入皮质类固醇相关可改善哮喘患者的肺功能，但没有提供足够的临床变量证据

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70044-9

C. Barreda , E.R. Alfaro , M.O. Caraballo

引用次数: 0

Estudio observacional sobre la influencia de los inhibidores de la bomba de protones en la incidencia de episodios cardiovasculares en pacientes tratados con clopidogrel 质子泵抑制剂对氯吡格雷治疗患者心血管发作发生率影响的观察研究

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70038-3

A. Gil Valiño , A.B. Ponce Piñón , M. Rodríguez Barreiro

{"title":"Estudio observacional sobre la influencia de los inhibidores de la bomba de protones en la incidencia de episodios cardiovasculares en pacientes tratados con clopidogrel","authors":"A. Gil Valiño , A.B. Ponce Piñón , M. Rodríguez Barreiro","doi":"10.1016/S2172-3761(11)70038-3","DOIUrl":"https://doi.org/10.1016/S2172-3761(11)70038-3","url":null,"abstract":"<div><h3>Objective</h3><p>To analyze the ratio of hospitalizations (NH) due to cardiovascular events (CE) and mortality in patients treated with clopidogrel in association or not to a proton pump inhibitors (PPI).</p></div><div><h3>Material and methods</h3><p>A retrospective cohort study was performed. Patients who were taking clopidogrel and who belonged to four health centers in PC in two different health areas from Galicia (the data was obtained of the health care homologation program of prescriptions from the Sub-Department of Pharmacy) were selected. The study period included January 2007-March 2009. Computerized medical records and records in paper format were analyzed to determine the prescription of PPI and whether the patient had any NH as a result of CE (AMI, ACS, stroke, TIA, bypass, stroke and/or peripheral artery disease). The data were analyzed using the SPSS statistical program and a descriptive and statistical analysis was performed (CHI-square test and ANOVA test).</p></div><div><h3>Results</h3><p>A total of 304 patients who fulfilled the inclusion criteria (65.5% male and 34.5% women) were enrolled. A total of 58.6% of the patients were treated with clopidogrel and a PPI. Of these 58.6% required hospitalization due to a CE versus 14.3%, when no PPI was associated. This means a 2.1 times higher risk of suffering a NH. Omeprazole was the PPI most used (73.65%).</p></div><div><h3>Conclusions</h3><p>The results obtained indicate a probable interaction between PPI and clopidogrel, it not being possible to establish its clinical importance. This does not imply that it may have serious repercussions for the health of the patients.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"9 3","pages":"Pages 76-80"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(11)70038-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

La aspirina no es eficaz en prevención primaria 阿司匹林对初级预防无效

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70031-0

M.V. Maestre Sánchez, R. Escudero Merino, T. Molina López

引用次数: 0

Los beneficios cardiovasculares del tratamiento con estatinas contrarrestan el ligero incremento del riesgo de desarrollar diabetes 他汀类药物治疗对心血管的好处抵消了糖尿病风险的轻微增加

Farmacéuticos de Atención Primaria Pub Date : 2011-01-01 DOI: 10.1016/S2172-3761(11)70033-4

B. García Robredo , V. Arroyo Pineda , C. Barreda Velázquez

引用次数: 0